The principal results of the International Immune Tolerance Study: a randomized dose comparison von Hay, Charles R.M., DiMichele, Donna M.

Volltext

Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO von W Collins, Peter, Chalmers, Elizabeth, Hart, Daniel, Jennings, Ian, Liesner, Ri, Rangarajan, Savita, Talks, Kate, Williams, Michael, R. M. Hay, Charles

Volltext

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom von Hay, Charles R.M., Palmer, Ben, Chalmers, Elizabeth, Liesner, Ri, Maclean, Rhona, Rangarajan, Savita, Williams, Michael, Collins, Peter W.

Volltext

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation von Hay, Charles R. M., Brown, S., Collins, P. W., Keeling, D. M., Liesner, R.

Volltext

Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO) von Wall, Caroline, Xiang, Hua, Palmer, Ben, Chalmers, Elizabeth, Chowdary, Pratima, Collins, Peter W., Fletcher, Simon, Hall, Georgina W., Hart, Daniel P., Mathias, Mary, Sartain, Paul, Shapiro, Susan, Stephensen, David, Talks, Kate, Hay, Charles R.M.

Volltext

Mortality in congenital hemophilia A – a systematic literature review von Hay, Charles R. M., Nissen, Francis, Pipe, Steven W.

Volltext

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies von Volkers, Peter, Hanschmann, Kay‐Martin, Calvez, Thierry, Chambost, Hervé, Collins, Peter W., Demiguel, Virginie, Hart, Daniel P., Hay, Charles R.M., Goudemand, Jenny, Ljung, Rolf, Palmer, Ben P., Santagostino, Elena, van Hardeveld, Ella M., van den Berg, Marijke, Keller‐Stanislawski, Brigitte

Volltext

General Surgery in Patients With a Bleeding Diathesis: How We Do It von Aryal, Kamal R., Wiseman, D., Siriwardena, Ajith K., Bolton-Maggs, Paula H. B., Hay, Charles R. M., Hill, James

Volltext

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy von Pasi, K. John, Rangarajan, Savita, Georgiev, Pencho, Mant, Tim, Creagh, Michael D, Lissitchkov, Toshko, Bevan, David, Austin, Steve, Hay, Charles R, Hegemann, Inga, Kazmi, Rashid, Chowdary, Pratima, Gercheva-Kyuchukova, Liana, Mamonov, Vasily, Timofeeva, Margarita, Soh, Chang-Heok, Garg, Pushkal, Vaishnaw, Akshay, Akinc, Akin, Sørensen, Benny, Ragni, Margaret V

Volltext

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011 von Collins, Peter W., Palmer, Benedict P., Chalmers, Elizabeth A., Hart, Daniel P., Liesner, Ri, Rangarajan, Savita, Talks, Katherine, Williams, Michael, Charles Hay, R.M.

Volltext

Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study von Scott, Martin J., Xiang, Hua, Hart, Daniel P., Palmer, Benedict, Collins, Peter W., Stephensen, David, Sima, Camelia S., Hay, Charles R. M.

Volltext

A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3 von Sutherland, Megan S., Cumming, Anthony M., Bowman, Mackenzie, Bolton-Maggs, Paula H.B., Bowen, Derrick J., Collins, Peter W., Hay, Charles R.M., Will, Andrew M., Keeney, Stephen

Volltext

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition) von Collins, Peter W., Chalmers, Elizabeth, Hart, Daniel P., Liesner, Ri, Rangarajan, Savita, Talks, Kate, Williams, Mike, Hay, Charles R.

Volltext

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation von Collins, Peter W., Hirsch, Sybil, Baglin, Trevor P., Dolan, Gerard, Hanley, John, Makris, Michael, Keeling, David M., Liesner, Ri, Brown, Simon A., Hay, Charles R.M.

Volltext

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV von Darby, Sarah C., Kan, Sau Wan, Spooner, Rosemary J., Giangrande, Paul L.F., Hill, Frank G.H., Hay, Charles R.M., Lee, Christine A., Ludlam, Christopher A., Williams, Michael

Volltext

Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency von Pike, Gillian N., Cumming, Anthony M., Hay, Charles R.M., Bolton-Maggs, Paula H.B., Burthem, John

Volltext

Emicizumab in Hemophilia A von Kruse-Jarres, Rebecca, Hay, Charles R.M, Buckner, Tyler W, Watson, Crystal, Recht, Michael, Aledort, Louis M

Volltext

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database von Peyvandi, Flora, Mahlangu, Johnny N., Pipe, Steven W., Hay, Charles R. M., Pierce, Glenn F., Kuebler, Peter, Kruse‐Jarres, Rebecca, Shima, Midori

Volltext

The use of fondaparinux in pregnancy von Elsaigh, Esra, Thachil, Jecko, Nash, Michael J., Tower, Clare, Hay, Charles R. M., Bullough, Sian, Byrd, Louise

Volltext

Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry von Hay, Charles R. M., Makris, Michael, Shima, Midori, Nagao, Azusa, Jiménez‐Yuste, Víctor, Skinner, Mark, Kessler, Craig M., Mackensen, Sylvia

Volltext